Skip to content

Analysis of risk factors for macular hole/pucker

Analysis of risk factors for macular hole/pucker

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092951
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular hole/pucker

Interventions

Case series:N/A

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Cases receiving ocular practices of macular hole/pucker; 2. In good general condition; 3. Voluntary participation;

Exclusion criteria

Exclusion criteria: 1. The patient cannot complete some or all of the examinations due to various reasons; 2. Mental illness or poor coordination; 3. Patients with systemic diseases affecting the eye, such as kidney failure, diabetes, and hypertension, were excluded; 4. Patients with reproductive system diseases, such as tumors of reproductive system, were excluded; 5. Patients with high myopia (=-6.00D) were excluded; 6. Patients with other vitreoretinal diseases and optic neuropathy, such as retinal detachment, retinal vein occlusion, diabetic retinopathy, age-related macular degeneration, retinitis pigmentosa, glaucoma, uveitis, were excluded; 7. Patients with a history of vitreoretinal therapy, including surgical treatment (such as vitrectomy, intravitreal drug injection, scleral cerclage), retinal photocoagulation and cryotherapy were excluded; 8. Patients with a history of ocular trauma, such as ocular contusion and penetrating corneal injury, was excluded; 9. Patients with complicated cataract caused by drugs such as glucocorticoids and other reasons were excluded; 10. Patients with sex hormone therapy and medication use affecting the hypothalamic-pituitary-gonadal axis were excluded; 11. Patients taking vitamin D and calcium supplements were excluded.

Design outcomes

Primary

MeasureTime frame
25-hydroxyvitamin D;

Secondary

MeasureTime frame
inflammatory factors;lipoprotein;sex hormones;

Countries

China

Contacts

Public ContactXuejiao Qin

The Second Hospital of Shandong University

qinxuejiao@hotmail.com+86 185 6008 7100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026